Rodent Surgical Services | Charles River

surgical services 

 
 

At Charles River, we understand how important high-quality surgical models that meet exacting scientific and regulatory standards are to your research. As the premier provider of surgically altered research models, we have the specialized skills and resources that allow us to tailor research models to your specific needs. We offer an array of surgical services on five species – rat, mouse, guinea pig, hamster, and gerbil – at five different AAALAC-accredited production facilities in the United States and multiple international sites. Our team of highly skilled surgeons is ready to provide you with healthy animals, exactly when you need them. Whether you need a basic research model or an entire discovery program, you can trust Charles River to be an integral part of your drug development program.


In order to ensure that we produce the exact surgically altered model for your research, we work with several different partners, including catheter and telemetry device manufacturers.


To download a copy of our 2012 Research Models and Services US Catalog,
click here.

 

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all
Want to find out how much your project will cost? Fill out a quote request form and one of our project specialists will be in touch with you shortly.
This sheet provides an overview of our surgical capabilities and lists the procedures offered in North America.

News & Events

view all
May 08 - Access Xenograft Data for Immunode...
May 01 - New GEMS Webinars Now Available On...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 18-Jun 21 - Newton, MA - 2012 Charles River Short Course on Laboratory Animal Scien...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.